证券代码：002476 证券简称：宝莫股份 公告编号：2025-048 山东宝莫生物化工股份有限公司 第七届董事会第十二次会议决议公告 公司《2025 年第三季度报告》（公告编号：2025-047）全文刊载于公司指定 信息披露媒体巨潮资讯网（http://www.cninfo.com.cn）。 本议案已经公司第七届董事会审计委员会 2025 年第五次会议审议通过，无 需提请股东会审议。 一、董事会会议召开情况 山东宝莫生物化工股份有限公司（以下简称"公司"）第七届董事会第十二 次会议于 2025 年 10 月 24 日以现场结合通讯表决的方式召开，现场会议地点： 公司会议室。本次会议通知于 2025 年 10 月 17 日以电子邮件等方式发出，会议 应出席董事 9 名，实际出席董事 9 名。公司监事、高级管理人员列席了会议，会 议由董事长陶旭城先生主持。本次会议的召集、召开符合有关法律、行政法规、 部门规章、规范性文件和《山东宝莫生物化工股份有限公司章程》的有关规定。 二、董事会会议审议情况 经与会董事充分审议并表决，本次会议通过了如下议案： 审议通过《关于公司<2025 年第三季度报告>的议案》 表决结果： ...

Financial Performance - Revenue for Q3 2025 reached ¥185,008,026.69, an increase of 6.46% compared to the same period last year[5] - Net profit attributable to shareholders was ¥22,015,754.64, representing a 33.80% increase year-over-year[5] - Net profit excluding non-recurring items was ¥16,101,963.40, up 35.68% from the previous year[5] - Total operating revenue for the current period reached CNY 452,590,068.00, an increase of 17.3% compared to CNY 385,872,584.58 in the previous period[23] - Net profit for the current period was CNY 37,867,985.87, representing a growth of 62.2% compared to CNY 23,367,306.31 from the previous period[24] - Total comprehensive income attributable to the parent company reached ¥37,867,985.87, an increase from ¥23,367,306.31 in the previous period, reflecting a significant growth[25] - Basic and diluted earnings per share improved to ¥0.0619, compared to ¥0.0382 in the prior period, indicating a positive trend in profitability[25] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,132,751,549.53, a 7.79% increase from the end of the previous year[5] - Total assets increased to CNY 1,132,751,549.53, compared to CNY 1,050,934,577.54 in the previous year, reflecting a growth of 7.8%[22] - Total liabilities rose to CNY 172,637,742.55, up from CNY 123,953,410.46, indicating a significant increase of 39.2%[22] - The company's total assets and liabilities will be detailed in the upcoming quarterly financial report[19] Cash Flow - Cash flow from operating activities showed a net outflow of ¥9,964,403.91, a decrease of 309.41% year-over-year[5] - Cash inflow from operating activities totaled ¥408,890,103.02, up from ¥357,513,888.77, showcasing a robust operational performance[25] - Net cash flow from operating activities was negative at -¥9,964,403.91, a decline from a positive ¥4,758,309.79 in the previous period, highlighting challenges in cash generation[25] - Cash flow from investing activities generated a net inflow of ¥75,074,080.55, down from ¥94,666,225.48, indicating reduced investment returns[26] - Cash flow from financing activities resulted in a net outflow of -¥8,401,567.36, compared to -¥6,600,068.17 previously, reflecting increased financing costs[26] - The ending cash and cash equivalents balance was ¥490,805,085.88, up from ¥356,655,384.19, indicating improved liquidity position[26] Accounts Receivable and Investments - Accounts receivable increased by 45.61% compared to the beginning of the period, primarily due to increased sales in the chemical business[11] - Accounts receivable rose to ¥247,718,814.38 from ¥170,128,388.84, indicating an increase of about 45.6%[20] - The company reported a significant increase of 4778.31% in construction in progress, attributed to capital investments in new projects[11] - The net cash flow from investment activities decreased by 20.70% compared to the previous year, mainly due to increased cash outflows[12] Shareholder Information - The company signed a share repurchase agreement with Hunan Zhongxin Industrial Development Co., Ltd., with a total repurchase price of ¥190,380,000.00 received, leaving a remaining balance of ¥38,504,874.01[16] - The company agreed to waive a portion of the penalty fees amounting to ¥1,325,543.59 related to the share repurchase agreement[17] - The largest shareholder, Sichuan Xingtianfu Hongling Enterprise Management Co., Ltd., pledged part of its shares, details of which were disclosed on August 8, 2025[18] - The company has not disclosed any significant changes in the top 10 shareholders or their participation in margin trading activities[13] - The company has not identified any related party relationships among the top shareholders[13] Future Outlook - The company continues to monitor the financial performance and market conditions to inform future strategic decisions[16] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[23] Research and Development - Research and development expenses for the current period were CNY 12,630,310.70, slightly down from CNY 13,615,051.94 in the previous period[24] Audit Information - The company did not undergo an audit for the third quarter financial report, which may affect stakeholder confidence in the reported figures[27]

Core Insights - The company reported a third-quarter revenue of 185 million, representing a year-on-year increase of 6.46% [1] - The net profit for the third quarter was 22.02 million, showing a year-on-year growth of 33.80% [1] - For the first three quarters, the total revenue reached 453 million, reflecting a year-on-year increase of 17.29% [1] - The net profit for the first three quarters was 37.87 million, which is a year-on-year increase of 62.06% [1]

Market Overview - As of October 27, the Shanghai Composite Index rose by 1.18%, closing at 3996.9445 points, while the Shenzhen Component Index increased by 1.51%, closing at 13489.403 points [1]. Top Gainers in Hunan Stocks - *ST Jingfeng opened at 7.690 and closed at 7.690, with a daily increase of 5.05%, maintaining the same price throughout the day, with a trading volume of 24,128 lots [2]. - Tianqiao Crane opened at 4.210 and closed at 4.340, rising by 4.08%, with a daily high of 4.350 and a low of 4.150, and a trading volume of 1,184,114 lots [2]. - Aoshikang opened at 39.620 and closed at 40.920, up by 3.52%, reaching a high of 41.240 and a low of 39.600, with a trading volume of 62,736 lots [2]. - Yanjinpuzi opened at 69.010 and closed at 70.350, increasing by 3.30%, with a daily high of 71.120 and a low of 68.500, and a trading volume of 36,492 lots [2]. - Hualing Steel opened at 5.740 and closed at 5.910, up by 2.96%, with a high of 5.970 and a low of 5.740, and a trading volume of 1,103,156 lots [2]. Top Losers in Hunan Stocks - Hengli Tui opened at 0.160 and closed at 0.150, experiencing a decline of 11.76%, with a daily high of 0.170 and a low of 0.150, and a trading volume of 611,606 lots [3]. - *ST Gaosi opened at 8.300 and closed at 8.350, down by 2.45%, with a high of 8.450 and a low of 8.130, and a trading volume of 58,408 lots [3]. - Changlan Technology opened at 17.700 and closed at 17.410, decreasing by 1.97%, with a high of 17.780 and a low of 17.200, and a trading volume of 45,737 lots [3]. - Hansen Pharmaceutical opened at 6.620 and closed at 6.510, down by 1.06%, with a high of 6.620 and a low of 6.480, and a trading volume of 94,306 lots [3]. - Hunan Investment opened at 5.730 and closed at 5.630, decreasing by 1.05%, with a high of 5.740 and a low of 5.580, and a trading volume of 171,054 lots [3].

10月23日，宝莫股份涨0.16%，成交额1.31亿元。两融数据显示，当日宝莫股份获融资买入额1317.82万 元，融资偿还1046.24万元，融资净买入271.58万元。截至10月23日，宝莫股份融资融券余额合计2.95亿 元。 融资方面，宝莫股份当日融资买入1317.82万元。当前融资余额2.95亿元，占流通市值的7.88%，融资余 额超过近一年90%分位水平，处于高位。 机构持仓方面，截止2025年6月30日，宝莫股份十大流通股东中，长城行业轮动混合A（002296）位居 第八大流通股东，持股196.56万股，持股数量较上期不变。长城安心回报混合A（200007）退出十大流 通股东之列。 责任编辑：小浪快报 资料显示，山东宝莫生物化工股份有限公司位于山东省东营市东营区西四路624号，成立日期1996年5月 3日，上市日期2010年9月15日，公司主营业务涉及聚丙烯酰胺、表面活性剂及相关化学品研发、生产、 销售及技术服务以及光伏发电等业务。主营业务收入构成为：油田用化学品88.91%，环保水处理 6.80%，非油田用化学品3.99%，其他(补充)0.30%。 截至10月20日，宝莫股份股东户数3.93万， ...

Core Viewpoint - Baomo Co., Ltd. (002476) reported that as of October 20, 2025, the total number of shareholders is 39,251 [1] Summary by Category - **Company Information** - Baomo Co., Ltd. has a total of 39,251 shareholders as of the specified date [1]

Market Overview - As of October 17, the Shanghai Composite Index fell by 1.95%, closing at 3839.7553 points, while the Shenzhen Component Index dropped by 3.04%, closing at 12688.936 points [1]. Top Gainers in Hunan Stocks - Hunan Silver opened at 7.820 and closed at 8.040, gaining 4.28% with a highest price of 8.270 and a lowest price of 7.640, trading volume reached 338.5494 million shares [2]. - Mengjie Co. opened at 3.760 and closed at 3.860, up by 2.93%, with a highest price of 3.920 and a lowest price of 3.720, trading volume was 43.4706 million shares [2]. - Bubugao opened at 5.610 and closed at 5.740, increasing by 2.50%, with a highest price of 6.100 and a lowest price of 5.610, trading volume was 275.9286 million shares [2]. - *ST Biological opened at 8.890 and closed at 9.010, up by 1.69%, with a highest price of 9.050 and a lowest price of 8.820, trading volume reached 2.1293 million shares [2]. - *ST Gauss opened at 8.400 and closed at 8.470, gaining 1.19%, with a highest price of 8.650 and a lowest price of 8.320, trading volume was 3.6155 million shares [2]. Top Losers in Hunan Stocks - Hengli Tui opened at 0.160 and closed at 0.150, down by 11.76%, with a highest price of 0.170 and a lowest price of 0.150, trading volume reached 61.1606 million shares [3]. - Taijia Co. opened at 20.650 and closed at 19.370, decreasing by 8.20%, with a highest price of 20.890 and a lowest price of 19.360, trading volume was 14.601 million shares [3]. - Changlan Technology opened at 18.280 and closed at 16.900, down by 7.55%, with a highest price of 18.300 and a lowest price of 16.880, trading volume reached 8.7081 million shares [3]. - Jinbei Electric opened at 12.700 and closed at 11.820, decreasing by 7.51%, with a highest price of 12.740 and a lowest price of 11.770, trading volume was 44.8327 million shares [3]. - Aoshikang opened at 39.800 and closed at 37.070, down by 6.86%, with a highest price of 39.800 and a lowest price of 36.900, trading volume reached 5.6638 million shares [3].

Group 1 - The core viewpoint of the articles is that Baomo Co., Ltd. is revising its Articles of Association and governance systems to enhance compliance and governance efficiency in line with regulatory updates and business development strategies [1][2]. Group 2 - The revision of the Articles of Association is driven by the need to align with recent regulatory policy updates and to optimize governance processes, including detailed rules for board and shareholder meetings [1][2]. - A total of 28 governance systems have been revised and established, including rules for shareholder meetings, board meetings, and independent director work systems, to ensure compliance with current laws and regulations [2]. - The revised Articles of Association and governance systems have been approved by the company's board and supervisory committee, pending final approval from the shareholders' meeting [2].

山东宝莫生物化工股份有限公司 市值管理制度 （2025 年 10 月制定） 第一章 总则 第一条 为进一步加强与规范山东宝莫生物化工股份有限公司（以下简称 "公司"）的市值管理工作，切实推动公司提升投资价值，增强投资者回报，维 护公司及投资者的合法权益，根据《中华人民共和国公司法》《中华人民共和国 证券法》《上市公司信息披露管理办法》《上市公司监管指引第 10 号——市值管 理》等相关法律、规范性文件和《山东宝莫生物化工股份有限公司章程》（以下 简称"《公司章程》"）等规定，结合公司实际情况，制定本制度。 第二条 本制度所称市值管理，是指以提高公司质量为基础，为提升公司投 资价值和股东回报能力而实施的战略管理行为。公司应当以高质量发展为基本前 提，稳步提升经营效率和盈利能力，着力将公司打造为经营业绩佳、创新能力强、 治理体系优、市场认可度高的一流上市公司。 第三条 公司质量是公司投资价值的基础和市值管理的关键环节。公司应当 立足提升公司质量，依法依规运用各类方式提升公司投资价值。 第二章 市值管理的目的和基本原则 第四条 市值管理主要目的是通过制定正确、科学的公司战略发展规划、完 善的公司治理，培育核心竞争力 ...

第一章 总则 第一条 为规范山东宝莫生物化工股份有限公司（以下简称"公司"）内幕 信息管理，加强内幕信息保密工作，维护信息披露的公平原则，保护广大投资者 的合法权益，根据《中华人民共和国公司法》《中华人民共和国证券法》（以下简 称"《证券法》"）、《上市公司信息披露管理办法》《深圳证券交易所股票上市规则》 等有关法律法规，以及《山东宝莫生物化工股份有限公司章程》（以下简称"《公 司章程》"）、公司《信息披露管理制度》的有关规定，结合公司实际情况，制定 本制度。 第二条 公司董事会应当按照深圳证券交易所相关规则要求及时登记和报 送内幕信息知情人档案，并保证内幕信息知情人档案真实、准确和完整，董事长 为主要责任人。董事会秘书负责办理公司内幕信息知情人的登记入档和报送事宜。 董事长与董事会秘书应当对内幕信息知情人档案的真实、准确和完整签署书面确 认意见。证券部门具体负责公司内幕信息登记备案的日常管理工作。 第二章 内幕信息的定义及范围 第三条 本制度所称内幕信息是指根据《证券法》相关规定，涉及公司的经 营、财务或者对公司证券市场价格有重大影响的尚未公开的信息。尚未公开是指 公司尚未在中国证监会指定、公司选定的公司信 ...